Qx8.5A.178.5.34 (42 and 48 repeats), CQ_SCA1_1_42-48
The cell line is not validated yet.
LUMCi023-A-4
General
iPSC Line |
|
| hPSCreg name | LUMCi023-A-4 |
| Cite as: | LUMCi023-A-4 |
| Alternative name(s) |
Qx8.5A.178.5.34 (42 and 48 repeats), CQ_SCA1_1_42-48
|
| iPSC line type | Human induced pluripotent stem cell (hiPSC) |
| Similar iPSC lines | No similar lines found. |
| Last update | 10th April 2026 |
| Notes | CRISPR/Cas modified clone containing 42 and 48 CAG repeats in the ATXN1 gene involved in spinocerebellar ataxia type 1. |
| User feedback | |
Provider |
|
| Generator | Leiden University Medical Center (LUMC) |
| Owner | Leiden University Medical Center (LUMC) |
| Distributors | |
| Derivation country | Netherlands |
External iPSC Databases |
|
| BioSamples | SAMEA122140176 |
General iPSC Information |
|
| Projects | |
| * Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
|
| Subclone of | |
iPSC Genetic Modification
| Disease/phenotype related modifications |
|
| Genetic modifications not related to a disease |
|
Donor Information
General Donor Information |
|
| Sex | female |
| Ethnicity | Caucasian |
Phenotype and Disease related information (Donor) |
|
| Diseases | No disease was diagnosed.
|
Donor Relations |
|
| All cell lines of this donor's relatives |
Has sister:
|
External Databases (Donor) |
|
| BioSamples | SAMEA6468664 |
Ethics
Also have a look at the ethics information for the parental line
LUMCi023-A
.
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
iPSC Derivation
General |
|
|
The source cell information can be found in the parental cell line
LUMCi023-A.
|
|
Reprogramming method |
|
Vector free reprogramming |
|
Other |
|
| Derived under xeno-free conditions |
Unknown |
| Derived under GMP? |
Unknown |
| Available as clinical grade? |
Unknown |
iPSC Culture Conditions
| Surface coating | Matrigel/Geltrex |
| Feeder cells |
No |
| Passage method |
Enzyme-free cell dissociation
ReLeSR
|
| CO2 Concentration | 5 % |
| Medium |
mTeSR™ 1
|
| Has Rock inhibitor (Y27632) been used at passage previously with this iPSC line? | Yes |
| Has Rock inhibitor (Y27632) been used at cryo previously with this iPSC line? | No |
| Has Rock inhibitor (Y27632) been used at thaw previously with this iPSC line? | Yes |
iPSC Characterisation
Analysis of undifferentiated iPSCs
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
| NANOG |
Yes |
|
|
|||
| POU5F1 (OCT-4) |
Yes |
|
|
|||
| SOX2 |
Yes |
|
|
Genotyping
Karyotyping (iPSC Line) |
|
| Has the iPSC line karyotype been analysed? |
Yes
46,XX
Karyotyping method:
Molecular karyotyping by SNP array
http:// |
Other Genotyping (iPSC Line) |
|
Login to share your feedback, experiences or results with the research community.